EDQM Stakeholder Event - Plasma Supply Continuity - European Directorate for the Quality of Medicines & HealthCare

This event provided an update on the latest developments in plasma supply in Europe, along with strategies to enhance and increase the safe collection and adequate supply of plasma and plasma-derived medicinal products (PDMP).

As part of a continuous effort to build upon recent and ongoing initiatives aimed at increasing and improving plasma collection and PDMP supply in European countries, and in the context of the changing regulatory landscape in the EU, this event covered the entire plasma-to-PDMP-to-patient chain.

Target audience

This event is of interest to professionals working in blood and plasma collection, PDMP manufacturing, patient and donor associations, blood and pharmaceutical regulation.

Download the programme

Download the presentations

26 March	27 March
Opening session Session 1: European developments Donor perspectives – Impact statement Session 2: Donor studies Session 3: Plasma processing and fractionation Patient perspectives – Impact statement	Patient perspectives – Impact statement Session 4: PDMPs – Supply and use (available soon) Session 5: Plasma as a strategic resource Session 6: Member state developments

Funders

The EDQM Stakeholder Event is co-funded by the European Directorate for the Quality of Medicines & HealthCare (EDQM) of the Council of Europe and the European Commission (EC).

The EDQM is a major contributor to developing internationally recognised guidelines and providing capacity-building tools, thus acting as an essential partner for blood establishments in Europe and beyond. In collaboration with international experts, the EDQM actively supports progress in the ﬁeld of substances of human origin by organising dedicated conferences and providing regular training courses on quality management.